Johnson, Gary L.
University of North Carolina at Chapel Hill · UNC Lineberger Comprehensive Cancer Center
7 papers on CoChatORCID 0000-0003-2867-0551
Most cited papers
- Verified
Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
Johnson, G. L., & Lapadat, R. (2002) · Science
Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling
Cited by 4,295
- Verified
Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer
Duncan, J. S., Whittle, M. C., Nakamura, K., Abell, A. N., Midland, A. A., Zawistowski, J. S., Johnson, N. L., Granger, D. A., Jordan, N. V., Darr, D. B., et al. (2012) · Cell
Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling
Cited by 732
- Verified
Unexplored therapeutic opportunities in the human genome
Oprea, T. I., Bologa, C. G., Brunak, S., Campbell, A., Gan, G. N., Gaulton, A., Gomez, S. M., Guha, R., Hersey, A., Holmes, J., et al. (2018) · Nature Reviews Drug Discovery
Computational Drug Discovery MethodsBioinformatics and Genomic Networks
Cited by 378
- Verified
Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex
Zawistowski, J. S., Bevill, S. M., Goulet, D. R., Stuhlmiller, T. J., Beltran, A. S., Olivares-Quintero, J. F., Singh, D., Sciaky, N., Parker, J. S., Rashid, N. U., et al. (2017) · Cancer Discovery
Melanoma and MAPK PathwaysChromatin Remodeling and Cancer
Cited by 180
- Verified
Molecular pathways: adaptive kinome reprogramming in response to targeted inhibition of the BRAF-MEK-ERK pathway in cancer
Johnson, G. L., Stuhlmiller, T. J., Angus, S. P., Zawistowski, J. S., & Graves, L. M. (2014) · Clinical Cancer Research
Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling
Cited by 129
- Verified
MEK inhibition in non-small cell lung cancer
Stinchcombe, T. E., & Johnson, G. L. (2014) · Lung Cancer
Lung Cancer Treatments and MutationsMelanoma and MAPK Pathways
Cited by 69
- Verified
PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2
Karim, M., Mishra, M., Lo, C.-W., Saul, S., Cagirici, H. B., Gourdelier, M., Ghita, L., Ojha, A., Tran, D. H. N., Agrawal, A., et al. (2025) · Nature Communications
SARS-CoV-2 and COVID-19 ResearchAutophagy in Disease and Therapy
Cited by 16
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free